SEC Form 4 · accession 0001354488-15-001661
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karthik Radhakrishnan
Officer — Chief Financial Officer
Period of report
Apr 8, 2015
Accepted (ET)
Apr 9, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 8, 2015 | M | 50,000 | — | A | 124,659 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Subscription Rights (Right to Buy)F1 | $0.55 | Apr 8, 2015 | M | 50,000 | D | Mar 13, 2015 | Apr 8, 2015 | See Footnote | 50,000 | 0 | D |
| Warrants (Right to Buy)F1,F2 | — | Apr 8, 2015 | M | 50,000 | A | Apr 8, 2015 | Apr 8, 2018 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Opexa Therapeutics, Inc. (the ?Company?) to all holders of the Company?s common stock and to holders of certain of the Company?s outstanding warrants. The subscription rights entitled each recipient thereof to purchase units (?Units?), each Unit consisting of one share of the Company?s common stock and one warrant representing the right to purchase one share of the Company?s common stock. The purchase price for each Unit was $0.55.
- F2Each warrant entitles the holder to purchase one share of the Company?s common stock at an exercise price of (i) $0.50 per share from the date of issuance through June 30, 2016 and (ii) $1.50 per share from July 1, 2016 through the expiration date of the warrants.